NCT06146933Completed
System Accuracy of BGM GL22
Evaluierung Der Systemgenauigkeit Des Blutglucosemonitoring Systems GL22 gemäß DIN EN ISO 15197:2015.
Institut fur Diabetes Karlsburg GmbHClinicalTrials.govdiagnostic test
Study focus
- Disease/Condition
- Diabetes
- Drug/Device/Intervention
- Glucometer Test
- Study type
- Interventional
- Intervention type
- diagnostic test
Sponsor & location
- Primary sponsor
- Institut fur Diabetes Karlsburg GmbH
- Location
- Karlsburg, Germany
Timeline & enrollment
- Phase
- N/A
- Start date
- Nov 01, 2023
- End date
- Nov 24, 2023
- Enrollment
- 113 participants
Primary outcome
Analysis of system accuracy based on DIN EN ISO 15197
Summary
This study assesses the system accuracy of a blood glucose monitoring system pursuant to ISO
 15197
ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsOther specified diabetes mellitus without complications
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06146933
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT06146933 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut fur Diabetes Karlsburg GmbH and is currently Completed. The study focuses on Diabetes. Target enrollment is 113 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.